title: Effect of acute and short-term administration of cholinomimetic drugs on corticosterone secretion in the rat.
abstract: Centrally acting cholinomimetic drugs have been proposed for the therapy of cognitive disorders in aged subjects. Among the possible adverse side effects of this class of compounds, of great relevance is the stimulatory action on the adrenocortical axis, in view of the toxicity of glucocorticoids for hippocampal neurons and the immune system. The aim of the present study was to evaluate in conscious male rats the effect of acute and short-term administration of three novel cholinomimetic drugs on the release of corticosterone. The potent agonist of muscarinic receptors RU 35963 strikingly increased corticosterone levels after acute but not after short-term (6 days) administration. Similar results were obtained after administration of the reversible inhibitor of cholinesterase, eptastigmine. In contrast to RU 35963 and eptastigmine, acute administration of a choline precursor, L-alpha-glycerylphosphorylcholine, only slightly affected plasma corticosterone concentrations after both acute and short-term administration. It is concluded that activation of adrenocortical function by cholinomimetic drugs is a short-lasting event which does not represent an important side effect of these compounds when given on a long-term basis.
authors.affiliation: Department of Pharmacology, University of Milan, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Cattaneo
authors.forename: G P
authors.initials: GP
authors.lastname: Bondiolotti
authors.forename: E E
authors.initials: EE
authors.lastname: Muller
authors.forename: D
authors.initials: D
authors.lastname: Cocchi
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D002802:Cholinesterases / Q000097:blood; D003345:Corticosterone / Q000097:blood / Q000378:metabolism*; D005997:Glycerylphosphorylcholine / Q000494:pharmacology*; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects*; D008297:Male; D010091:Oximes / Q000494:pharmacology; D010277:Parasympathomimetics / Q000494:pharmacology*; D010830:Physostigmine / Q000031:analogs & derivatives / Q000494:pharmacology; D010913:Pituitary-Adrenal System / Q000187:drug effects*; D011725:Pyridines / Q000494:pharmacology; D011863:Radioimmunoassay; D051381:Rats; D011921:Rats, Inbred WKY
chemical_list: D002800:Cholinesterase Inhibitors; D010091:Oximes; D010277:Parasympathomimetics; D011725:Pyridines; C084624:RU 35963; D005997:Glycerylphosphorylcholine; C052450:physostigmine heptyl; D010830:Physostigmine; D002802:Cholinesterases; D003345:Corticosterone